Add like
Add dislike
Add to saved papers

Associations of Liver Stiffness Measured by Ultrasound Shear-Wave Elastography With Portal Hypertension and Circulatory Failure in Individuals With Fontan Circulation.

Background: The Fontan operation palliates single-ventricle congenital heart disease but causes hepatic congestion with associated progressive hepatic fibrosis. Objective: To evaluate associations between liver stiffness measured using ultrasound shear-wave elastography (SWE) in patients with Fontan palliation and occurrence of portal hypertension and Fontan circulatory failure during follow-up. Methods: This retrospective study included 119 individuals ≥10 years old (median age, 19.1 years; 61 female, 58 male) with Fontan circulation who underwent liver ultrasound with 2D SWE from January 1, 2015, to January 1, 2022 and had ≥1 year of clinical follow-up (unless experiencing earlier outcome-related events). Median liver stiffness from initial ultrasound was documented. VAST (varices, ascites, splenomegaly, and thrombocytopenia) scores (range, 0-4) were determined as a marker of portal hypertension on initial ultrasound and ≥1-year follow-up imaging (ultrasound, CT, or MRI). Composite clinical outcome for Fontan circulatory failure (death, mechanical circulatory support, cardiac transplantation, or unexpected Fontan-related hospitalization) was assessed. Analysis included Wilcoxon rank-sum test, logistic regression analysis with stepwise variable selection, and ROC analysis. Results: Median initial liver stiffness was 2.22 m/s. Median initial VAST score was 0 (IQR: 0-1); median follow-up VAST score was 1 (IQR: 0-2) (p=.004). Fontan circulatory failure occurred in 37/119 (31%) patients (median follow-up, 3.4 years). Initial liver stiffness was higher in patients with follow-up VAST score ≥1 (2.37 m/s) than follow-up VAST score 0 (2.08 m/s) (p=.005), and in patients with (2.43 m/s) than without (2.10 m/s) Fontan circulatory failure at follow-up (p<.001). Initial liver stiffness was the only significant independent predictor of Fontan circulatory failure (OR=3.76; p<.001); age, sex, Fontan operation type, dominant ventricular morphology, and initial VAST score were not independent predictors. Initial liver stiffness had AUC of 0.70 (sensitivity 79%, specificity 57%; threshold, >2.11 m/s) for predicting follow-up VAST score ≥1, and 0.74 (sensitivity 84%, specificity 52%; threshold, >2.12 m/s) for predicting Fontan circulatory failure. Conclusion: In patients with Fontan circulation, increased initial liver stiffness was associated with portal hypertension and circulatory failure during follow-up, although had moderate performance in predicting these outcomes. Clinical Impact: Ultrasound SWE may play a role in post-Fontan surveillance, supporting tailored medical and surgical care.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.
Urinary Tract Infections: Core Curriculum 2024.American Journal of Kidney Diseases 2023 October 31

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app